

(Alliance News) - Roquefort Therapeutics PLC on Monday said its Mesodermal Killer cell programme has reached a "significant" milestone.


(Alliance News) - The following is a round-up of earnings of London-listed companies, issued on Wednesday and not separately reported by Alliance News...


(Alliance News) - Roquefort Therapeutics PLC on Monday said it has filed an international phase PCT patent for its anti-cancer mRNA and RNA oligonucle...


Roquefort Therapeutics PLC - London-based biotechnology company, focused on developing medicines for hard-to-treat cancers - Announces the development...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued Thursday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


(Alliance News) - Roquefort Therapeutics PLC on Monday said its recent in vivo study targeting midkine-expressing cancers has shown "significant" succ...